Age and post-traumatic stress disorder (PTSD) are key factors that affect how coherently sexually abused children are able to recount traumatic events, according to a new study published in the journal Heliyon.
A study published in Psychological Reports showed that after 3.5 months of practicing Transcendental Meditation (TM), most of the 34 tertiary-level students at Maharishi Institute (MI) -- all of whom were initially diagnosed with PTSD by mental health professionals -- went below clinical thresholds as measured by standard assessments. Students also experienced relief from depression. A comparison group from University of Johannesburg (UJ) with the same diagnosis received no treatment and showed no change in their symptoms.
A new study, published in The Journal of Clinical Investigation, establishes that the stress hormone epinephrine sets off a cascade of biochemical reactions that favor breast cancer growth and spread in chronically stressed patients.
Directly activating a gene important to exciting our excitatory neurons and associated with major depression may help turn around classic symptoms like social isolation and loss of interest, at least for males, scientists report.
An antidepressant drug used to treat obsessive-compulsive disorder could save people from deadly sepsis, new research suggests.
What happens in the brain when we feel discomfort? Researchers at Karolinska Institutet in Sweden are now one step closer to finding the answer. In a new study published in the journal Molecular Psychiatry they identify which pathways in the mouse brain control behaviour associated with aversion.
Lifetime adversity and increased neural processing during a traumatic event combine to increase the frequency of intrusive traumatic memories and the distress they cause, according to a new study in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
Support from managers and colleagues, as well as a positive attitude, are most likely to enable a more long-term return to work for employees after a sickness absence, according to a new review of research led by the University of East Anglia (UEA). The review evaluated the impact of personal and social factors on sustainable return to work after ill-health due to musculoskeletal disorders, such as joint and back pain, and common mental health conditions, for example stress, depression or anxiety.
New therapeutic molecules developed at Toronto's Centre for Addiction and Mental Health (CAMH) show promise in reversing the memory loss linked to depression and aging. These molecules not only rapidly improve symptoms, but remarkably, also appear to renew the underlying brain impairments causing memory loss in preclinical models.
For the first time, scientists discovered how neuroactive steroids naturally found in the brain and bloodstream inhibit the activity of a specific kind of protein called Toll-like receptors (TLR4), which have been known to play a role in inflammation in many organs, including the brain.